Improving patient outcome through science
We are recruiting a postdoctoral researcher with strong interest in pancreatic cancer biology and immunotherapy. Washington University in St. Louis is one of the NIH-funded Pancreatic Cancer SPORE (Specialized Program of Research Excellence) with heavy emphasis in development of targeted and immunotherapy-based therapies. Capitalizing on the strengths of the institution in genomics and proteomics, our program is at the cutting-edge of making novel discoveries necessary to fuel therapeutic development. The position will be mentored by Drs. Kian Lim and Andrea Wang-Gillam, both physician-scientists who are dedicated in improving patient outcome and nurturing the next generation of researchers to combat this lethal disease.
The candidate will be NIH-funded and lead the work in exploring signaling rewiring following targeted therapies such as ERK inhibition) in KRAS-mutant pancreatic cancer and participate in developing novel immunotherapeutic regimens based on novel findings made in our labs. The candidate will have the opportunity to work with conventional cancer cell lines, patient-derived xenograft and genetically-engineered mouse models and establish collaborations with the Washington University Proteomics Core and the Genome Institute.
The position requires a recent or soon-to-be doctoral graduate with relevant training background including but not limited to molecular, cellular, tumor or immuno-biology. The candidate must exhibit strong motivation to excel in his/her career, should have strong organizational skills and be able to communicate effectively in English. Experience in mouse experiments, common “wet lab” skills including Western Blot, PCR, cell culture, flow cytometry and cloning is required. Our program believes in strong mentorship and success of next-generation researchers.